Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Bone Marrow
100%
Growth Defects
100%
Methotrexate
100%
Bone Growth
100%
Bone Resorption
100%
Marrow Adiposity
100%
Folinic Acid
100%
Osteoclast Formation
66%
Growth Plate
50%
Interleukin-1β
33%
Spongiosa
33%
Methotrexate Chemotherapy
33%
Survivors
16%
Pediatric Patients
16%
Long-term Treatment
16%
Neutralizing Antibodies
16%
Osteoblast
16%
Protective Effect
16%
Plasma-induced
16%
Preventive Treatment
16%
Apoptosis
16%
Columnar
16%
Pediatric Cancer Patients
16%
Chondrocytes
16%
Young Rats
16%
Bone Marrow Cells
16%
Normal Bone Marrow
16%
Methotrexate Treatment
16%
Metaphyseal
16%
Metaphysis
16%
Growth Suppression
16%
High-dose Methotrexate (HD-MTX)
16%
Skeletal Growth
16%
Damage Effect
16%
Anti-IL-1
16%
Chondrocyte Apoptosis
16%
Metaphyseal Bone
16%
Immunology and Microbiology
Osteolysis
100%
Methotrexate
100%
Bone Growth
100%
Rat
100%
Blood Plasma
44%
Osteoclastogenesis
44%
Interleukin 1
33%
Chondrocyte
22%
Programmed Cell Death
22%
Neutralizing Antibody
11%
Bone Marrow Cell
11%
Drug Megadose
11%
Osteoblast
11%
Metaphysis
11%
Growth Inhibition
11%
In Vitro
11%
Pharmacology, Toxicology and Pharmaceutical Science
Methotrexate
100%
Folinic Acid
100%
Rat
100%
Interleukin 1
33%
Chemotherapy Regimens
22%
Malignant Neoplasm
11%
Pathophysiology
11%
Neutralizing Antibody
11%
Antidote
11%